(Q34019785)

English

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

blood coagulation disease

1 reference

based on heuristic

inferred from title

author name string

ALKJAERSIG N

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

FLETCHER AP

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

SHERRY S

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 April 1962

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

917-934

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

The maintenance of a sustained thrombolytic state in man. I. Induction and effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

The mechanism of clot dissolution by plasmin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

xi-Aminocaproic acid: an inhibitor of plasminogen activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=290992

5 July 2018

Anticoagulant effect of incubated fibrinogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on paracoagulation. Role of antithrombin VI

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nature of the thrombin-inhibiting effect of incubated fibrinogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticoagulant action of TAMe and AFIF

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A new anticoagulant derived from fibrinogen]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrinolysis and fibrinolytic activity in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Appearance of an inhibitor of thromboplastin formation during proteolysis of fibrinogen]

1 reference

https://pubmed.ncbi.nlm.nih.gov/13860492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI104547

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34019785&oldid=1632121505"